A BILL 
To amend the Public Health Service Act to authorize the 
Director of the National Institutes of Health to make 
awards to outstanding scientists, including physician-sci-
entists, to support researchers focusing on pediatric re-
search, including basic, clinical, translational, or pediatric 
pharmacological research, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Pediatricians Accel-
4
erate Childhood Therapies Act of 2019’’ or the ‘‘PACT 
5
Act of 2019’’. 
6
22:57 Oct 01, 2019
H4519
2 
•HR 4519 IH
SEC. 2. TRANS-NIH AWARDS FOR EARLY-CAREER PEDI-
1
ATRIC RESEARCHERS. 
2
Part G of title IV of the Public Health Service Act 
3
(42 U.S.C. 288 et seq.) is amended by adding at the end 
4
the following new section: 
5
‘‘SEC. 489A. TRANS-NIH AWARDS FOR EARLY-CAREER PEDI-
6
ATRIC RESEARCHERS. 
7
‘‘(a) IN GENERAL.—The Director of the NIH shall 
8
make awards to outstanding scientists, including physi-
9
cian-scientists, to support researchers focusing on pedi-
10
atric research, including basic, clinical, translational, or 
11
pediatric pharmacological research. 
12
‘‘(b) PRIORITY RESEARCH TOPIC AREAS.—In car-
13
rying out subsection (a), the Director of NIH, in consulta-
14
tion with the Director of the Eunice Kennedy Shriver Na-
15
tional Institute of Child Health and Human Development 
16
and the directors of other national research institutes and 
17
national centers that participate within the Trans-NIH 
18
Pediatric Research Consortium, shall— 
19
‘‘(1) establish priority research topic areas, in-
20
formed by external stakeholders including research 
21
institutions, research societies, patient organizations, 
22
and industry; and 
23
‘‘(2) consider opportunities to align such pri-
24
ority pediatric research topic areas with current and 
25
22:57 Oct 01, 2019
H4519
3 
•HR 4519 IH
future priorities of the National Institutes of Health, 
1
including— 
2
‘‘(A) childhood cancer; 
3
‘‘(B) precision medicine, genetics, and 
4
genomics; 
5
‘‘(C) rare diseases and disorders, such as 
6
sickle cell disease, and other diseases and dis-
7
orders with significant unmet training needs; 
8
‘‘(D) fetal, placental, and neonatal develop-
9
ment; and 
10
‘‘(E) child and adolescent mental health. 
11
‘‘(c) PRIORITY AWARDS.—In making awards under 
12
this section, the Director of NIH shall— 
13
‘‘(1) give priority to researchers, including phy-
14
sician-scientists, who have a demonstrated pro-
15
ficiency in conducting pediatric research, but have 
16
not yet achieved research independence at the time 
17
of their application; and 
18
‘‘(2) give special consideration to researchers 
19
from populations that are historically underrep-
20
resented in pediatric medical research. 
21
‘‘(d) REQUIREMENTS.—The Director of NIH— 
22
‘‘(1) shall require recipients of awards under 
23
this section to use such awards to support pediatric 
24
research activities, including costs associated with 
25
22:57 Oct 01, 2019
H4519
4 
•HR 4519 IH
laboratory staff and other costs associated with the 
1
conduct of research; and 
2
‘‘(2) may allow recipients of awards under this 
3
section to use such awards for costs associated with 
4
receiving guidance and training from senior re-
5
searchers as necessary to help such recipients reach 
6
a state of research independence, including con-
7
ferences and other meeting participation. 
8
‘‘(e) SUPPLEMENT, NOT SUPPLANT.—Awards made 
9
under this section shall be used to supplement, and not 
10
supplant, other funding for research career development 
11
awards.’’. 
12
SEC. 3. TRANS-NIH PEDIATRIC CONSORTIUM. 
13
Title IV of the Public Health Service is amended by 
14
inserting after section 409D (42 U.S.C. 284h) the fol-
15
lowing new section: 
16
‘‘SEC. 409D–1. TRANS-NIH PEDIATRIC CONSORTIUM. 
17
‘‘(a) ESTABLISHMENT.—The Director of NIH shall 
18
establish and maintain a consortium to be known as the 
19
Trans-NIH Pediatric Research Consortium (in this sec-
20
tions referred to as the ‘Consortium’) to coordinate pedi-
21
atric research programs across the National Institutes of 
22
Health. 
23
22:57 Oct 01, 2019
H4519
5 
•HR 4519 IH
‘‘(b) MEMBERSHIP.——The members of the Consor-
1
tium shall consist of representatives of multiple national 
2
research institutes and national centers. 
3
‘‘(c) CHAIR.—The Chair of the Consortium shall be 
4
the Director of the Eunice Kennedy Shriver National In-
5
stitute of Child Health and Human Development (or the 
6
Director’s designee). 
7
‘‘(d) DUTIES.—In coordinating pediatric research 
8
programs across the National Institutes of Health, the 
9
Consortium shall— 
10
‘‘(1) establish pediatric research priorities; 
11
‘‘(2) identify gaps and opportunities for re-
12
search collaborations involving multiple national re-
13
search institutes and national centers; and 
14
‘‘(3) identify opportunities to develop the next 
15
generation of pediatric researchers. 
16
‘‘(e) CONSULTATION.—The Consortium shall consult 
17
regularly with external experts in the field of pediatric re-
18
search, including children’s hospitals, children’s research 
19
institutions, patient organizations, and other stake-
20
holders.’’. 
21
Æ 
22:57 Oct 01, 2019
H4519
